Advertisement
Obstetrics/Gynecology
Subscribe to Obstetrics/Gynecology
View Sample

FREE Email Newsletter

Medical College Of Wisconsin To Study New Incontinence Device

August 6, 2012 3:08 pm | News | Comments

The Medical College of Wisconsin (MCW) has begun a clinical study of InTone®, a new, FDA-approved medical device that treats female urinary incontinence. The 12-week study will evaluate the effectiveness of InTone in women with stress incontinence, urge incontinence, or mixed (stress AND urge) incontinence.

Personal Med Launched to Advance Women’s Pelvic Health

May 3, 2012 6:00 am | News | Comments

Today Personal Medical Corp. (“Personal Med”) was officially launched as an independent medical device company focusing on advances in women’s pelvic health. The company was previously a wholly owned subsidiary of SRS Medical in Billerica MA.

Cervical Ripening Balloon from Cook Medical Now Available with Stylet

February 8, 2012 5:43 am | News | Comments

BLOOMINGTON, Ind.--(BUSINESS WIRE)--Cook Medical's Cervical Ripening Balloon will now be available with a guiding stylet that offers added stiffness to facilitate placement when conditions for inducing labor are unfavorable. The addition of a stylet helps obstetricians position the balloon...

Advertisement

High-risk, Underserved Women Benefited from MRI Screening for Breast Cancer

September 21, 2011 8:37 am | by AACR | News | Comments

Tweet •    Results based on lower-cost MRI screenings for high-risk, uninsured or under-insured women.•    MRI screenings found more cancer cases in high-risk women than mammography.•    Underserved women can benefit from...

Johnson & Johnson Makes Strong Progress in First Year of Initiative to Improve Health of Millions of Women and Children in the Developing World

September 20, 2011 8:37 am | by Bio-Medicine.Org | News | Comments

NEW BRUNSWICK, N.J., Sept. 20, 2011 /- Johnson & Johnson (NYSE: JNJ ) today announced important progress made in the inaugural year of the Company's comprehensive effort designed to improve the health of as many as 120 million women and children each year in developing countries by...

Trig Medical Presents Innovative Labor Progression Management System at ISUOG 21st World Congress

September 15, 2011 7:36 pm | by Bio-Medicine.Org | News | Comments

LOS ANGELES, Sept. 15, 2011 /- Trig Medical, Inc. , a health technology company specializing in labor progression management and interventional ultrasound guidance, today announced its participation at the International Society of Ultrasound in Obstetrics and Gynecology's (ISUOG) ...

Temperature Monitoring Device From Digitron Helps Pork Farms Take a Big Bite of the Food Market

September 15, 2011 12:36 am | by Bio-Medicine.Org | News | Comments

TORQUAY, England, September 15, 2011 /- When you're producing 1.8 million baked goods each week product quality and food safety is crucial for brand confidence and sustained business growth. A Nottingham-based company which specialises in pork pies and other popular savouries and...

Samsung Medison America Welcomes Brian Keith as Sales General Manager, USA

August 31, 2011 11:39 am | by Bio-Medicine.Org | News | Comments

CYPRESS, Calif., Aug. 31, 2011 /- Samsung Medison America appoints Brian Keith as Sales General Manager, USA to address a growing demand for its expansive line of Ultrasound platforms. Mr. Keith will be responsible for the US sales organization and its management in Samsung Medison...

Advertisement

Alere partners with VitaPath to market fetal health test

August 11, 2011 9:43 am | by Mass High Tech: The Journal of New England Technology | News | Comments

Alere Inc., a healthcare management firm in Waltham, has licensed from Foster City, Calif.-based VitaPath Genetics a genetic test, in addition to gaining the right to develop other fetal health products with VitaPath.

Jetty.ca Features Essential Patient and Physician Resources for Critical Childbirth Complications

August 9, 2011 5:43 pm | by Bio-Medicine.Org | News | Comments

MISSISSAUGA, Ontario and CAMBRIDGE, Mass., Aug. 9, 2011 /- Theramed Corporation, Glenveigh Medical, and Body1, Inc. announce the launch of a website on critical childbirth complications at http://www.jetty.ca . In addition to providing product information for ebb™ and jetty™,...

Auxilium Pharmaceuticals, Inc. Announces Promotion of Dr. James P. Tursi to Chief Medical Officer

August 8, 2011 8:46 am | by Bio-Medicine.Org | News | Comments

MALVERN, Pa., Aug. 8, 2011 /- Auxilium Pharmaceuticals, Inc. (NASDAQ: AUXL ), a specialty biopharmaceutical company, today announced that Dr. James P. Tursi has been promoted to Chief Medical Officer. Dr. Tursi will report to Armando Anido, Chief Executive Officer and President of...

Cambridge Technology Company ionscope helps researchers make heart discovery

August 4, 2011 7:35 am | by RealWire | News | Comments

A discovery that may one day help the recovery of some people who have suffered a heart attack has been made with the help of ionscope's SICM equipment.Cambridge UK, Thursday 4 August 2011 - SICM, a high resolution microscopy technique, has been used by a team of researchers to identify a...

Unapproved Emergency Birth Control Medicine Possibly in U.S. Distribution May Be Ineffective and Unsafe

August 1, 2011 9:45 am | by Bio-Medicine.Org | News | Comments

SILVER SPRING, Md., Aug. 1, 2011 /PRNewswire-USNewswire/ -- The U.S. Food and Drug Administration (FDA) is warning U.S. consumers not to use the emergency birth control medicine labeled as Evital. These products may be counterfeit versions of the "morning after pill" and may not be safe...

Advertisement

Marshall Edwards Announces Publication of Pre-Clinical Study Showing Activity in Chemotherapy-Resistant Ovarian Cancer Stem Cells

July 27, 2011 6:41 am | by Bio-Medicine.Org | News | Comments

SAN DIEGO, July 27, 2011 /- Marshall Edwards, Inc.(Nasdaq: MSHL ), an oncology company focused on the clinical development of novel therapeutics targeting cancer metabolism, announced the publication of results from a pre-clinical study of NV-128 showing activity in chemotherapy-resistant...

Two Additional Private Payers Provide Coverage for Posterior Tibial Nerve Stimulation Delivered Using the Uroplasty Urgent® PC Neuromodulation System

July 18, 2011 4:41 am | by Bio-Medicine.Org | News | Comments

MINNEAPOLIS, July 18, 2011 /- Uroplasty, Inc. (NASDAQ: UPI ), a medical device company that develops, manufactures and markets innovative proprietary products to treat voiding dysfunctions, today announced that two additional private insurance payers will cover  posterior tibial...

Spirus Medical acquired by Tokyo firm

July 6, 2011 5:35 am | by Mass High Tech: The Journal of New England Technology | News | Comments

Spirus Medical Inc., a West Bridgewater maker of endoscope insertion devices, has been sold to Tokyo-based Olympus Corp.

Hologic to Release Third Quarter Fiscal 2011 Operating Results on Monday, August 1, 2011

June 28, 2011 8:36 am | by Bio-Medicine.Org | News | Comments

BEDFORD, Mass., June 28, 2011 /- Hologic, Inc. (Hologic or the Company) (Nasdaq: HOLX ), a leading developer, manufacturer and supplier of premium diagnostics, medical imaging systems and surgical products dedicated to serving the healthcare needs of women, today announced plans to...

Columbia Laboratories' NDA for PROCHIEVE® Vaginal Progesterone Gel Accepted for Filing by FDA

June 27, 2011 3:34 am | by Bio-Medicine.Org | News | Comments

LIVINGSTON, N.J. and MORRISTOWN, N.J., June 27, 2011 /- Columbia Laboratories, Inc. (Nasdaq: CBRX ) and Watson Pharmaceuticals, Inc. (NYSE: WPI ) today announced that the U.S. Food and Drug Administration (FDA) has accepted for filing Columbia's New Drug Application (NDA) for PROCHIEVE...

Centrix Pharmaceutical, Inc. Announces Agreement With CutisPharma, Inc. to Promote FIRST® - Progesterone VGS Compounding Kit

June 23, 2011 4:41 am | by Bio-Medicine.Org | News | Comments

BIRMINGHAM, Ala. June 23, 2011 /- Centrix Pharmaceutical, Inc., a privately-held specialty pharmaceutical company focused on Pediatrics and Women's Health, announces a promotional agreement with CutisPharma, Inc., a Woburn, Massachusetts based company. The partnership will include the...

Transgenomic, Inc. Launches Best-in-Class Next-Generation Sequencing Test for Nuclear Mitochondrial Disorders at the 2011 United Mitochondrial Disease Foundation Meeting

June 16, 2011 9:33 am | by Bio-Medicine.Org | News | Comments

OMAHA, Neb., June 16, 2011 /- Transgenomic, Inc. (OTC/BB: TBIO) today announced the launch of the Nuclear Mitome Test, a genetic test to aid physicians in the diagnosis of mitochondrial disorders. The Nuclear Mitome Test, employs next-generation sequencing technology to identify mutations...

Theramed Corporation to Launch Glenveigh Products, ebbâ„¢ and jettyâ„¢ at the Society of Obstetricians and Gynecologists of Canada

June 14, 2011 9:35 am | by Bio-Medicine.Org | News | Comments

MISSISSAUGA, Ontario, June 14, 2011 /- Theramed Corporation ("Theramed") announces that it will launch ebb™ and jetty™ at the 67th Clinical Meeting of the Society of Obstetricians and Gynecologists of Canada. The two newly developed medical devices are to be used to advance...

Thomson Reuters - NPR Health Poll Finds Three-Quarters of Americans Support Government Insurance Subsidies for Birth Control Pills

June 10, 2011 2:31 am | by Bio-Medicine.Org | News | Comments

ANN ARBOR, Mich. and WASHINGTON, June 10, 2011 /- American consumers are broadly in favor of oral contraceptive coverage by both private and government-subsidized health insurance plans, according to the Thomson Reuters-NPR Health Poll. (Logo:...

Reportlinker Adds Global Market for Hormonal Contraceptives and Infertility Drugs, 2011-2018

May 31, 2011 1:32 am | by Bio-Medicine.Org | News | Comments

NEW YORK, May 31, 2011 /- Reportlinker.com announces that a new market research report is available in its catalogue: Global Market for Hormonal Contraceptives and Infertility Drugs, 2011-2018...

OVA1 Improves Ovarian Cancer Detection Over CA 125 Blood Test and Clinical Assessment

May 24, 2011 5:34 am | by Bio-Medicine.Org | News | Comments

MADISON, N.J. and AUSTIN, Texas, May 24, 2011 /- A paper published in the June issue of Obstetrics & Gynecology demonstrated that adding OVA1 to a physician's preoperative assessment of a woman's ovarian mass would identify more ovarian cancers than a physician's preoperative...

Florida Legislature Refuses to Limit Mercury in Vaccines

May 9, 2011 8:36 am | by Bio-Medicine.Org | News | Comments

SILVER SPRING, Md., May 9, 2011 /PRNewswire-USNewswire/ – CoMeD – On Friday, May 6, 2011, in Tallahassee, Florida, a Republican State Senator filed an amendment to regulate vaccines containing mercury in Florida.  The amendment would have made it illegal to buy, sell,...

X
You may login with either your assigned username or your e-mail address.
The password field is case sensitive.
Loading